PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2010 | 51 | 2 |

Tytuł artykułu

Investigation of the 22q11.2 candidate region in patients with midline facial defects with hypertelorism

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
Midline facial defects with hypertelorism (MFDH) are mainly characterized by ocular hypertelorism and bifid nose. They are often associated with structural and functional anomalies of the central nervous system similar to those found in 22q11.2 deletion syndromes. In addition, there are some isolated reports of MFDH and 22q11.2 deletion. These findings suggest that MFDH may be part of the spectrum of 22q11.2 deletion syndromes. To test this hypothesis, 10 individuals with MFDH were analyzed by fluorescent in situ hybridization (FISH), but no 22q11.2 deletion was detected. In view of this result, the TBX1 gene located within the 22q11.2 candidate region was screened. A new sequence variant (1132GA) was identified in one patient. This variant was not found in 110 control individuals genotyped. Considering the rarity of this condition and results of this study, the involvement of the 22q11.2 chromosomal region in the pathogenesis of MFDH could not be excluded.

Wydawca

-

Rocznik

Tom

51

Numer

2

Opis fizyczny

p.219-221,ref.

Twórcy

autor
  • Department of Medical Genetics, University of Campinas [UNICAMP], Tessalia Vieira de Camargo Street 126, 13084-971. Campinas, SP, Brazil
  • Department of Medical Genetics, University of Campinas [UNICAMP], Tessalia Vieira de Camargo Street 126, 13084-971. Campinas, SP, Brazil
  • Department of Medical Genetics, University of Campinas [UNICAMP], Tessalia Vieira de Camargo Street 126, 13084-971. Campinas, SP, Brazil
  • Department of Medical Genetics, University of Campinas [UNICAMP], Tessalia Vieira de Camargo Street 126, 13084-971. Campinas, SP, Brazil
  • Department of Medical Genetics, University of Campinas [UNICAMP], Tessalia Vieira de Camargo Street 126, 13084-971. Campinas, SP, Brazil

Bibliografia

  • Campbell LE, Daly E, Toal F, Stevens A, Azuma R, Catani M, et al. 2006. Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain 129: 1218-1228.
  • Giffoni SDA, Gonçalves VMG, Zanardi VA, Gil-da-Silva-Lopes VL, 2006. Cerebellar involvement in Midline Facial Defects with Ocular Hypertelorism. Cleft Palate-Craniofac J 43: 466-470.
  • Gil-da-Silva-Lopes VL, Giffoni SD, 2006. Central nervous system abnormalities on midline facial defects with hypertelorism detected by magnetic resonance image and computed tomography. Arq Neuropsiquiatr 64: 916-920.
  • Gil-da-Silva-Lopes VL, Maciel-Guerra AT, 2007. A clinical study of 31 individuals with midline facial defects with hypertelorism and a guideline for follow-up. Arq Neuropsiquiatr 65: 396-401.
  • Gong W, Gottlieb S, Collins J, Blescia A, Dietz H, Goldmuntz E, et al. 2001. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet 38: E45.
  • Kirkpatrick SJ, Pauli RM, 1998. Frontonasal malformation and deletion of 22q11. Am J Med Genet 75: 443-444.
  • Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, Sobotka A, et al. 2006. Tbxl haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103: 7729-7734.
  • Rauch A, Devriendt K, Koch A, Rauch R, Gewillig M, Kraus C, et al. 2004. Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients. J MedGenet 41: e40.
  • Simon TJ, Ding L, Bish JP, McDonald-McGinn DM, Zackai EH, Gee J, 2005. Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11.2 deletion syndrome: an integrative study. Neuroimage 25: 169-180.
  • Stratton RF, Payne RM, 1997. Frontonasal malformation with tetralogy of Fallot associated with a submicroscopic deletion of 22q11. Am J Med Genet 69: 287-289.
  • Zoupa M, Seppala M, Mitsiadis T, Cobourne MT, 2006. Tbx1 is expressed at multiple sites of epithelial-mesenchymal interaction during early development of the facial complex. Int J Dev Biol 50: 505-510.
  • Zweier C, Sticht H, Aydin-Yaylagul I, Campbell CE, Rauch A, 2007. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am J Hum Genet 80: 510-517.
  • Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, et al. 2003. Matsuoka R. Role of TBX1 in human del22q11.2 syndrome. Lancet 362: 1366-1373.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-f20e0c42-3d7a-4711-88b3-379ae9227b31
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.